(S)-VQW-765 ((S)-AQW-051) is an orally active, selective and effective alpha7 nicotinic ACh receptor (nAChR) partial agonist. (S)-VQW-765 has potential applications in cognitive disorders related to neurological diseases, such as Alzheimers disease or schizophrenia[1][2].
Molecular Weight:
294.39
Purity:
98.00
Formula:
C19H22N2O
Target:
nAChR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
